GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol
Abstract Background The burden of opioid use BEYOND GRAPE SEED disorder (OUD) has been increasing in North America.Administration of medication-assisted treatments (MATs) for OUD on an individual-dose basis has been shown to affect patient responses to treatment, proving to be, on occasion, dangerous.A genetic basis has been identified for some MAT